The role of matrix metalloproteinases in pathogenesis of renal disease

The role of matrix metalloproteinases in pathogenesis of renal disease

Bibliographic Details
Main Authors:	I N Bobkova, L V Kozlovskaia, O A Li
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2008-06-01
Series:	Терапевтический архив
Subjects:	review matrix metalloproteninases tissue inhibitors of matrix metalloproteinases inhibitor of activator of type i plasminogen chronic glomerulonephritis diabetic nephropathy acute renal failure renal carcinoma inhibitors of ace blockers of angiotensin ii receptor
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/30215

Similar Items

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
by: Qiao Zhen-kui, et al.
Published: (2013-01-01)

THE ROLE OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS IN THE DEVELOPMENT OF COMPLICATIONS OF KIDNEY DISEASE IN CHILDREN
by: G. A. Sukhanova, et al.
Published: (2015-06-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

The role of matrix metalloproteinases in early and late gonarthrosis manifestations
by: Ekaterina V. Gladkova
Published: (2020-09-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

Effect of preservation solutions UW and EC on the expression of matrix metalloproteinase II and tissue inhibitor of metalloproteinase II genes in rat kidney
by: Tadeusz Sulikowski, et al.
Published: (2012-01-01)

Clinical implications of urine matrix metalloproteinases assay in patients with chronic glomerulonephritis
by: Ol'ga Aleksandrovna Li, et al.
Published: (2009-08-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
by: D. I. Haidash, et al.
Published: (2019-12-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
by: Duda Izabela, et al.
Published: (2020-03-01)

Matrix metalloproteinases 2, 7, 8, 9 and their type 1 tissue inhibitor in serum of renal cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2017-05-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

Are matrix metalloproteinases the missing link?
by: F Mannello, et al.
Published: (2005-05-01)

Metalloproteinase and tissue inhibitor of metalloproteinase in tuberculosis and malignant pleural effusion
by: Nesriene Mohamad El Margoushy, et al.
Published: (2013-04-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Inhibition of Tissue Matrix Metalloproteinases Interferes with Mycobacterium tuberculosis-Induced Granuloma Formation and Reduces Bacterial Load in a Human Lung Tissue Model
by: Venkata R. Parasa, et al.
Published: (2017-12-01)

ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling
by: Peter E. Westerweel, et al.
Published: (2012-01-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Challenges in Matrix Metalloproteinases Inhibition
by: Helena Laronha, et al.
Published: (2020-05-01)

Relationship between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity
by: Pelin Uysal, et al.
Published: (2019-02-01)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1, matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation
by: Bitan Naik, et al.
Published: (2016-01-01)

The serum levels of circulating matrix metalloproteinase MMP-9, MMP-2/TIMP-2 complex and TIMP-1 do not change significantly during normal pregnancy: a pilot study
by: Ritva Nissi, et al.
Published: (2021-01-01)

Association between expression of tissue inhibitors of metalloproteinases-1, matrix metalloproteinase-2, and matrix metalloproteinase-9 genes and axillary lymph nodes metastasis in patients with breast cancer
by: Alireza Abdollahi, et al.
Published: (2019-01-01)

Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy
by: A G Ovchinnikov, et al.
Published: (2009-05-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

The relationship between the first episode of wheezing and matrix metalloproteinases-9 and MMP-2 and tissue inhibitors of MMP-1 levels in preterm infants
by: Rabia Gonul Sezer, et al.
Published: (2013-01-01)

Evaluation of the Effects of Increased Parathyroid Hormone (PTH) Following Myocardial Infarction on the Expressions Level of Matrix Metalloproteinase 9 and Tissue Inhibitor Metalloproteinase
by: Faezeh Hoseini, et al.
Published: (2017-11-01)

Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation
by: Thomas Fischer, et al.
Published: (2019-06-01)

Expressions of matrix metalloproteinases 1 and 3 and their tissue inhibitors in the conjunctival tissue and fibroblasts cultured from conjunctivochalasis
by: Min-Hong Xiang, et al.
Published: (2017-04-01)

Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys
by: Youn Ho Shin, et al.
Published: (2014-12-01)

Matrix Metalloproteinase Enzyme Family
by: Ozlem Goruroglu Ozturk
Published: (2013-04-01)

Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients
by: Magdalena Groblewska, et al.
Published: (2010-04-01)

Role of matrix metalloproteinases in the development of airway inflammation and remodeling
by: V. Lagente, et al.
Published: (2005-10-01)

Cannot write session to /tmp/vufind_sessions/sess_lf4t51rq8pr4k0pecof5pct5se